{
    "clinical_study": {
        "@rank": "56923", 
        "arm_group": [
            {
                "arm_group_label": "omiganan mid dose", 
                "arm_group_type": "Active Comparator", 
                "description": "omiganan mid dose once daily application for 12 weeks"
            }, 
            {
                "arm_group_label": "omiganan high dose", 
                "arm_group_type": "Active Comparator", 
                "description": "omiganan high dose once daily application for 12 weeks"
            }, 
            {
                "arm_group_label": "Vehicle group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Vehicle once daily application for 12 weeks"
            }, 
            {
                "arm_group_label": "omiganan low dose", 
                "arm_group_type": "Active Comparator", 
                "description": "omiganan low dose once daily application for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate th safety and efficacy of one-daily topical\n      application of CLS001 low, mid and high dose compared to vehicle gel in subjects with\n      papulopustular rosacea."
        }, 
        "brief_title": "A Twelve Week Safety and Efficacy Study in Rosacea", 
        "condition": "Papulopustular Rosacea", 
        "condition_browse": {
            "mesh_term": "Rosacea"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnosis of papulopustular rosacea (at least 15 lesions)\n\n        Exclusion Criteria:\n\n          -  nodular rosacea or subtype 3\n\n          -  clinically significant abnormal findings that would interfere with study objectives"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01784133", 
            "org_study_id": "CLS001-CO-PR-001"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "omiganan mid dose", 
                    "omiganan high dose", 
                    "omiganan low dose"
                ], 
                "intervention_name": "omiganan", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Vehicle group", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "rosacea", 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35209"
                    }, 
                    "name": "Radiant Research Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Monica", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90404"
                    }, 
                    "name": "ATS Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06511"
                    }, 
                    "name": "The Savin Center, PC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boca Raton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33486"
                    }, 
                    "name": "Skin Care Research, Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dunedin", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34698"
                    }, 
                    "name": "Dunedin Research Specialists"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32204"
                    }, 
                    "name": "North Florida Dermatology Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46256"
                    }, 
                    "name": "Dawes Fretzin Clinical Research Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warren", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48088"
                    }, 
                    "name": "Grekin Skin Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14625"
                    }, 
                    "name": "Rochester General Medical Group Center for Dermatology at Linden Oaks"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stoney Brook", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11790"
                    }, 
                    "name": "Derm Research Center of NY Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }, 
                    "name": "Wake Resarch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Oregon Dermatology and Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johnson City", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37674"
                    }, 
                    "name": "TriCities Skin and Cancer"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37215"
                    }, 
                    "name": "Tennessee Clinical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "Progressive Clinical Research, PA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84117"
                    }, 
                    "name": "Dermatology Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23507"
                    }, 
                    "name": "Virginia Clinical Research Inc."
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in inflammatory lesion count", 
            "safety_issue": "No", 
            "time_frame": "0, 1, 3, 6, 9 and 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01784133"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Success on IGA defined as clear or almost clear", 
            "safety_issue": "No", 
            "time_frame": "Week 12"
        }, 
        "source": "Cutanea Life Sciences, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cutanea Life Sciences, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}